Table 2.
Clinical-demographic characteristics at baseline in the whole cohort and in the hereditary/sporadic subgroups
Whole cohort (n = 42) | Hereditary (n = 23) | Sporadic (n = 19) | Statistic | |
---|---|---|---|---|
Age at examination | 53 ± 13 | 47 ± 12 | 61 ± 10 | 0.67 |
Sex (females, %) | 13 (31%) | 6 (25%) | 7 (39%) | 0.52 |
Age at onset | 46 (28;56) | 33 ± 15 | 53 ± 8 | 0.003 |
Disease duration | 10 (3;15) | 13 (7;19) | 3 (2;14) | 0.008 |
Death during follow-up (no. of cases) | 2 (4.7%) | 0 | 2 (10.5%) | 0.2 |
SARA | 13.5 (9;17.5) | 14 ± 7 | 14 ± 5 | 0.08 |
UMSARS I | 7.5 (5;12) | 5 (3;10) | 9 (6;14) | 0.04 |
UMSARS II | 16.3 ± 7.4 | 12 (10;19) | 19 (12;21) | 0.29 |
SCOPA-Aut | 7 (3;14) | 4 (3;12) | 12 (7;15) | 0.03 |
OHQ | 0 (0;4) | 0 (0;2.5) | 0 (0;5.3) | 0.32 |
Statistically significant differences are reported in bold